These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10789932)

  • 1. Long-term follow-up of portacaval shunt in glycogen storage disease type 1B.
    Corbeel L; Van Lierde S; Jaeken J
    Eur J Pediatr; 2000 Apr; 159(4):268-72. PubMed ID: 10789932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Choi Y; Yi NJ; Ko JS; Moon JS; Suh SW; Lee JM; Jeong JH; Kim H; Lee HW; Lee KW; Suh KS
    Transplantation; 2016 Mar; 100(3):585-92. PubMed ID: 26360666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for glycogen storage disease types I, III, and IV.
    Matern D; Starzl TE; Arnaout W; Barnard J; Bynon JS; Dhawan A; Emond J; Haagsma EB; Hug G; Lachaux A; Smit GP; Chen YT
    Eur J Pediatr; 1999 Dec; 158 Suppl 2(Suppl 2):S43-8. PubMed ID: 10603098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
    Corbeel L; Hue L; Lederer B; De Barsy T; Van den Berghe G; Devlieger H; Jaeken J; Bracke P; Eeckels R
    Pediatr Res; 1981 Jan; 15(1):58-61. PubMed ID: 6259580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dietary therapy and portacaval shunt in the management of a patient with type Ib glycogen storage disease.
    Borowitz SM; Greene HL; Gay JC; Neblett WW
    J Pediatr Gastroenterol Nutr; 1987; 6(4):635-9. PubMed ID: 3123638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I glycogen storage disease: nine years of management with cornstarch.
    Chen YT; Bazzarre CH; Lee MM; Sidbury JB; Coleman RA
    Eur J Pediatr; 1993; 152 Suppl 1():S56-9. PubMed ID: 8319727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of living donor liver transplantation for glycogen storage disorders in children.
    Iyer SG; Chen CL; Wang CC; Wang SH; Concejero AM; Liu YW; Yang CH; Yong CC; Jawan B; Cheng YF; Eng HL
    Liver Transpl; 2007 Jun; 13(6):848-52. PubMed ID: 17539004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for type I and type IV glycogen storage disease.
    Selby R; Starzl TE; Yunis E; Todo S; Tzakis AG; Brown BI; Kendall RS
    Eur J Pediatr; 1993; 152 Suppl 1(Suppl 1):S71-6. PubMed ID: 8319729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of growth in glycogen storage disease type 1.
    Mundy HR; Hindmarsh PC; Matthews DR; Leonard JV; Lee PJ
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):332-9. PubMed ID: 12608939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.
    Corbeel L; Boogaerts M; Van den Berghe G; Everaerts MC; Marchal G; Eeckels R
    Eur J Pediatr; 1983; 140(3):273-5. PubMed ID: 6578929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation for glycogen storage disease type Ib.
    Kasahara M; Horikawa R; Sakamoto S; Shigeta T; Tanaka H; Fukuda A; Abe K; Yoshii K; Naiki Y; Kosaki R; Nakagawa A
    Liver Transpl; 2009 Dec; 15(12):1867-71. PubMed ID: 19938129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portacaval shunt in siblings for type I glycogenosis.
    Liebschutz D; Soper RT
    J Pediatr Surg; 1976 Aug; 11(4):557-61. PubMed ID: 823318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).
    Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S20-34. PubMed ID: 12373567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.
    Weinstein DA; Wolfsdorf JI
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S35-9. PubMed ID: 12373568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-size liver transplantation for glycogen storage disease.
    Ji HF; Wang WL; Shen Y; Zhang M; Liang TB; Wu J; Xu X; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):106-8. PubMed ID: 19208526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia.
    Faivre L; Houssin D; Valayer J; Brouard J; Hadchouel M; Bernard O
    J Inherit Metab Dis; 1999 Aug; 22(6):723-32. PubMed ID: 10472532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.